English
中文
CAS:93479-97-1
Appearance:White Powder
Storage:Store at RT，2 years
Purity:98.00%
Use and synthesis method:
Biochemical research. Glibenclamide is the second generation of sulfonylurea oral hypoglycemic drug, the main mechanism of its hypoglycemic effect is to stimulate the secretion of insulin by islet beta cells, and partially improve the sensitivity of surrounding tissues to insulin. It binds and dissociates insulin receptors faster than glibenclamide and is less likely to cause severe hypoglycemia.
Physical shape:
White solid.
Solubility:
This product is dissolved in trichloromethane, very slightly dissolved in ethanol, almost insoluble or insoluble in water; Almost insoluble or insoluble in 0.1mol/L hydrochloric acid solution, very slightly soluble in 0.1mol/L sodium hydroxide solution
Note：Product information may be optimized and upgraded. Please refer to the actual label information for accuracy.
